Found: 24
Select item for more details and to access through your institution.
The genomics of acute myeloid leukemia in children.
- Published in:
- Cancer & Metastasis Reviews, 2020, v. 39, n. 1, p. 189, doi. 10.1007/s10555-020-09846-1
- By:
- Publication type:
- Article
Experience with ponatinib in paediatric patients with leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 2, p. 363, doi. 10.1111/bjh.16338
- By:
- Publication type:
- Article
Klinefelter syndrome and 47,XYY syndrome in children with B cell acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 5, p. 843, doi. 10.1111/bjh.14258
- By:
- Publication type:
- Article
Constitutive loss of DNMT3A causes morbid obesity through misregulation of adipogenesis.
- Published in:
- eLife, 2022, p. 1, doi. 10.7554/eLife.72359
- By:
- Publication type:
- Article
Observation and Management of Juvenile Myelomonocytic Leukemia and Noonan Syndrome-Associated Myeloproliferative Disorder: A Real-World Experience †.
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2749, doi. 10.3390/cancers16152749
- By:
- Publication type:
- Article
Cohesin Subunit RAD21 Regulates the Differentiation and Self-Renewal of Hematopoietic Stem and Progenitor Cells.
- Published in:
- Stem Cells, 2023, v. 41, n. 10, p. 971, doi. 10.1093/stmcls/sxad058
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions | Optimal Timing of Blinatumomab for the Treatment of B-Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 3, p. 159, doi. 10.1016/j.clml.2022.12.011
- By:
- Publication type:
- Article
Optimal Timing of Blinatumomab for the Treatment of B-Lymphoblastic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S99, doi. 10.1016/S2152-2650(21)01226-X
- By:
- Publication type:
- Article
How the COG is Approaching the High-Risk Patient with ALL: Incorporation of Immunotherapy into Frontline Treatment.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Can recombinant technology address asparaginase Erwinia chrysanthemi shortages?
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 10, p. 1, doi. 10.1002/pbc.29169
- By:
- Publication type:
- Article
Prognostic impact of minimal residual disease at the end of consolidation in NCI standard‐risk B‐lymphoblastic leukemia: A report from the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 4, p. 1, doi. 10.1002/pbc.28929
- By:
- Publication type:
- Article
Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Incidence and predictors of treatment-related conjugated hyperbilirubinemia during early treatment phases for children with acute lymphoblastic leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prevention of mercaptopurine-induced hypoglycemia using allopurinol to reduce methylated thiopurine metabolites.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated <italic>Erwinia</italic> asparaginase, pegcrisantaspase: A report from the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2018, v. 65, n. 3, p. 1, doi. 10.1002/pbc.26873
- By:
- Publication type:
- Article
Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Ethnic disparities relative to disease features and outcomes in children with acute myeloid leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
MLL-rearranged acute lymphoblastic leukaemia stem cell interactions with bone marrow stroma promote survival and therapeutic resistance that can be overcome with CXCR4 antagonism.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 6, p. 785, doi. 10.1111/bjh.12205
- By:
- Publication type:
- Article
Murine Models of Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.854973
- By:
- Publication type:
- Article
SARS‐CoV‐2 infections in patients enrolled on the Children's Oncology Group standard‐risk B‐cell acute lymphoblastic leukemia trial, AALL1731.
- Published in:
- EJHaem, 2023, v. 4, n. 3, p. 745, doi. 10.1002/jha2.697
- By:
- Publication type:
- Article
Use of Allopurinol to Mitigate 6-Mercaptopurine Associated Gastrointestinal Toxicity in Acute Lymphoblastic Leukemia.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.01129
- By:
- Publication type:
- Article